Neogenomics (NEO) Cash from Operations (2010 - 2026)

Neogenomics (NEO) has reported Cash from Operations for 17 consecutive years, with 8137000.0 the latest figure, recorded in Q1 2026.

• Cash from Operations for Q1 2026 came in at 8137000.0, up 67.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 22420000.0 (up 194.57% YoY), and the FY2025 annual result was 5230000.0, down 25.53% from the prior year.
• Cash from Operations was 8137000.0 for Q1 2026 at Neogenomics, down from 1343000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 20330000.0 in Q2 2025 and troughed at 29040000.0 in Q1 2022.
• Average Cash from Operations over 5 years is 3754705.88, with a median of 3685000.0 recorded in 2022.
• Year-over-year, Cash from Operations tumbled 1414.03% in 2022 and surged 997.42% in 2024.
• Over 5 years, Cash from Operations stood at 3685000.0 in 2022, then jumped by 582.61% to 17784000.0 in 2023, then plunged by 44.89% to 9800000.0 in 2024, then slumped by 86.3% to 1343000.0 in 2025, then plunged by 705.88% to 8137000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 8137000.0 in Q1 2026, 1343000.0 in Q4 2025, and 8884000.0 in Q3 2025.